Global Cardiovascular Disease Diagnostics Market to Reach US$12.4 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. San Jose, CA (Vocus/PRWEB) February 23, 2011 Major players profiled in the report include Abbott Diagnostics, Alere Inc., Beckman Coulter, Inc., Cholestech Corp., GE HealthCare, Nanogen Inc., Philips Medical Systems, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., St Jude Medical Inc., among others. http://www.prweb.com/releases/cardiovascular_disease/diagnostics_in_vitro_vivo/prweb8153547.htm